All lobbying clients
Immix Biopharma, Inc.
Immix Biopharma, Inc. has been represented by 5 lobbying firms in 14 filings in 2026, with $460,000 in reported spending; the newest was posted November 4, 2026.
Biopharmaceutical company
$460,000
Reported spend
14
Filings counted
5
Outside firms hired
0
Bills named
Who filed for this client
5
- Continental Strategy, LLC $260,000
- Tarplin, Downs & Young, LLC $100,000
- Axadvocacy Government Relations $80,000
- First Principles Strategies, LLC $20,000
- Brownstein Hyatt Farber Schreck, LLP $0
Reported by year
1 year
- 2026 $460,000
Issues lobbied
3
Agencies and chambers lobbied
6
- HOUSE OF REPRESENTATIVES
- SENATE
- Health & Human Services, Dept of (HHS)
- Agriculture, Dept of (USDA)
- Food & Drug Administration (FDA)
- Health Resources & Services Administration (HRSA)
Recent filings
14 total
Registration
View →
Q3 report
View →
Registration
View →
Q3 report
View →
Q3 report
View →
Q3 report
View →
Q2 report
View →
Q2 report
View →
Q2 report
View →
Registration
View →
Q1 report
View →
Registration
View →
Q1 reportNo activity
View →
Registration
View →
Brownstein Hyatt Farber Schreck, LLP
First Principles Strategies, LLC
First Principles Strategies, LLC
Tarplin, Downs & Young, LLC
Continental Strategy, LLC
Axadvocacy Government Relations
Tarplin, Downs & Young, LLC
Continental Strategy, LLC
Axadvocacy Government Relations
Axadvocacy Government Relations
Tarplin, Downs & Young, LLC
Tarplin, Downs & Young, LLC
Continental Strategy, LLC
Continental Strategy, LLC